Oriane Chausiaux, PhD, and Shamus Husheer, PhD, explain the hardships faced by 1 in 7 American couples who have difficulties with fertility. These issues range from a lack of…
ZURICH (Reuters) – Swiss pharma group Roche’s drug Perjeta (pertuzumab) significantly extended the lives of women with HER2-positive breast cancer compared to a placebo, according to new data…
The Misfit “Shine” is a new device that empowers people to track their daily activity goals in a simple and elegant way. Sonny Vu and Sridhar Iyengar, co-founders…
Oriane Chausiaux, PhD, and Shamus Husheer, PhD, discuss DuoFertility, a new method to aid couples struggling with infertility. The program monitors over 20,000 physiological measurements to guide couples on the best ways to conceive…
NEW YORK (Reuters Health) – Despite its known cardiotoxic effect, trastuzumab is associated with a relatively low risk of congestive heart failure in women being treated for HER2-positive…
NEW YORK (Reuters Health) – The increased risk of breast cancer in women who received radiotherapy above the diaphragm for treatment of Hodgkin’s lymphoma (HL) persists for at…
Brachytherapy has become increasingly and commonly used in the United States to treat breast cancer after a lumpectomy. Although this therapy and the standard treatment, whole breast irradiation,…
NEW YORK (Reuters Health) – The combination of estrogen and raloxifene seems to reduce menopausal symptoms and appears not to increase the risk of endometrial hyperplasia, researchers from…
NEW YORK (Reuters Health) – Getting a second opinion of surgical breast pathology often leads to changes that impact treatment in women with node-negative breast cancer or ductal…
NEW YORK (Reuters Health) – A randomized, multicenter trial has confirmed that myofascial physical therapy is an effective treatment for women with newly symptomatic interstitial cystitis/painful bladder syndrome…